SAN DIEGO, July 27 /PRNewswire-FirstCall/ -- Neurocrine Biosciences (Nasdaq: NBIX) announces the following Webcast:

    What:     Neurocrine Biosciences Webcast
    When:     July 30, 2009 @ 8:30am EDT
    Where:    http://www.videonewswire.com/event.asp?id=60921
    How:      Live over the Internet -- Simply log on to the web at the
              address above.
    Contact:  Jane Sorenson of Neurocrine Biosciences, +1-858-617-7653.

If you are unable to participate during the live webcast, the call will be archived on the Web site www.neurocrine.com.

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world including endometriosis, anxiety, depression, pain, diabetes, benign prostatic hyperplasia (BPH), irritable bowel syndrome (IBS) and other neurological and endocrine related diseases and disorders. Neurocrine Biosciences, Inc. news releases are available through the Company's website via the internet at http://www.neurocrine.com

SOURCE Neurocrine Biosciences, Inc.